메뉴 건너뛰기




Volumn 9, Issue 2, 2014, Pages

Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GALANTAMINE; CHOLINESTERASE INHIBITOR;

EID: 84896782077     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089454     Document Type: Article
Times cited : (108)

References (62)
  • 1
    • 80052266213 scopus 로고    scopus 로고
    • The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics
    • Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10: 698-712.
    • (2011) Nat Rev Drug Discov , vol.10 , pp. 698-712
    • Karran, E.1    Mercken, M.2    De Strooper, B.3
  • 2
    • 4344580888 scopus 로고    scopus 로고
    • Strategies for disease modification in Alzheimer's disease
    • Citron M (2004) Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 5: 677-685.
    • (2004) Nat Rev Neurosci , vol.5 , pp. 677-685
    • Citron, M.1
  • 3
    • 62649174753 scopus 로고    scopus 로고
    • Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
    • Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, et al. (2009) Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 106: 4012-4017.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 4012-4017
    • Koffie, R.M.1    Meyer-Luehmann, M.2    Hashimoto, T.3    Adams, K.W.4    Mielke, M.L.5
  • 4
    • 23444448170 scopus 로고    scopus 로고
    • Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy
    • DOI 10.1523/JNEUROSCI.1879-05.2005
    • Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, et al. (2005) Dendritic spine abnormalities in APP transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25: 7278-7287. (Pubitemid 41113944)
    • (2005) Journal of Neuroscience , vol.25 , Issue.31 , pp. 7278-7287
    • Spires, T.L.1    Meyer-Luehmann, M.2    Stern, E.A.3    McLean, P.J.4    Skoch, J.5    Nguyen, P.T.6    Bacskai, B.J.7    Hyman, B.T.8
  • 6
    • 53549099647 scopus 로고    scopus 로고
    • Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology in vivo
    • Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, et al. (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology in vivo. Nat Med 14: 1106-1111.
    • (2008) Nat Med , vol.14 , pp. 1106-1111
    • Schilling, S.1    Zeitschel, U.2    Hoffmann, T.3    Heiser, U.4    Francke, M.5
  • 7
    • 77951776829 scopus 로고    scopus 로고
    • Alzheimer's disease: Strategies for disease modification
    • Citron M (2010) Alzheimer's disease: strategies for disease modification. Nat Rev Drug Discov 9: 387-398.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 387-398
    • Citron, M.1
  • 8
    • 79959987552 scopus 로고    scopus 로고
    • Combination therapy for Alzheimer's disease
    • Patel L, Grossberg GT (2011) Combination therapy for Alzheimer's disease. Drugs Aging 28: 539-546.
    • (2011) Drugs Aging , vol.28 , pp. 539-546
    • Patel, L.1    Grossberg, G.T.2
  • 9
    • 0035251675 scopus 로고    scopus 로고
    • Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease
    • DOI 10.1016/S0006-3223(00)01109-4, PII S0006322300011094
    • Maelicke A, Samochock M, Jostock R, Fehrenbacher A, Ludwig J, et al. (2001) Allosteric Sensitization of Nicotinic Receptors by Galantamine, a New Treatment Strategy for Alzheimer's Disease. Biol Psychiatry 49: 279-288. (Pubitemid 32178437)
    • (2001) Biological Psychiatry , vol.49 , Issue.3 , pp. 279-288
    • Maelicke, A.1    Samochocki, M.2    Jostock, R.3    Fehrenbacher, A.4    Ludwig, J.5    Albuquerque, E.X.6    Zerlin, M.7
  • 10
    • 0030972169 scopus 로고    scopus 로고
    • Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y
    • Peng X, Gerzanich V, Anand R, Wang F, Lindstrom J (1997) Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 51: 776-784. (Pubitemid 27224682)
    • (1997) Molecular Pharmacology , vol.51 , Issue.5 , pp. 776-784
    • Peng, X.1    Gerzanich, V.2    Anand, R.3    Wang, F.4    Lindstrom, J.5
  • 11
    • 0001237770 scopus 로고
    • CNS nicotine receptors. Possible therapeutic targets in neurodegenerative disorders
    • Court JA, Perry EK (1994) CNS nicotine receptors. Possible therapeutic targets in neurodegenerative disorders. CNS Drugs 2: 216-233.
    • (1994) CNS Drugs , vol.2 , pp. 216-233
    • Court, J.A.1    Perry, E.K.2
  • 12
    • 0032507506 scopus 로고    scopus 로고
    • Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta- amyloid toxicity
    • DOI 10.1016/S0006-8993(98)00138-3, PII S0006899398001383
    • Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, et al. (1998) Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res 792: 331-334. (Pubitemid 28267549)
    • (1998) Brain Research , vol.792 , Issue.2 , pp. 331-334
    • Kihara, T.1    Shimohama, S.2    Urushitani, M.3    Sawada, H.4    Kimura, J.5    Kume, T.6    Maeda, T.7    Akaike, A.8
  • 14
    • 33846185442 scopus 로고    scopus 로고
    • Nicotinic component of galantamine in the regulation of amyloid precursor protein processing
    • DOI 10.1016/j.cbi.2006.11.008, PII S0009279706003401
    • Lenzken SC, Lanni C, Govoni S, Lucchelli A, Schettini G, et al. (2007) Nicotinic component of galantamine in the regulation of amyloid precursor protein processing. Chem Biol Interact 165: 138-145. (Pubitemid 46091660)
    • (2007) Chemico-Biological Interactions , vol.165 , Issue.2 , pp. 138-145
    • Lenzken, S.C.1    Lanni, C.2    Govoni, S.3    Lucchelli, A.4    Schettini, G.5    Racchi, M.6
  • 16
    • 78650057569 scopus 로고    scopus 로고
    • Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors
    • Takata K, Kitamura Y, Saeki M, Terada M, Kagitani S, et al. (2010) Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors. J Biol Chem 285: 40180-40191.
    • (2010) J Biol Chem , vol.285 , pp. 40180-40191
    • Takata, K.1    Kitamura, Y.2    Saeki, M.3    Terada, M.4    Kagitani, S.5
  • 17
    • 80855166582 scopus 로고    scopus 로고
    • Galantamine treatment in Alzheimer's disease: Response and long-term outcome in a routine clinical setting
    • Wallin ÅK, Wattmo C, Minthon L (2011) Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting. Neuropsychiatr Dis Treat 7: 565-576.
    • (2011) Neuropsychiatr Dis Treat , vol.7 , pp. 565-576
    • Wallin, Å.K.1    Wattmo, C.2    Minthon, L.3
  • 18
  • 19
    • 79955674781 scopus 로고    scopus 로고
    • Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients
    • Keller C, Kadir A, Forsberg A, Porras O, Nordberg A (2011) Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. J Alz Dis 24: 109-123.
    • (2011) J Alz Dis , vol.24 , pp. 109-123
    • Keller, C.1    Kadir, A.2    Forsberg, A.3    Porras, O.4    Nordberg, A.5
  • 22
    • 84871862823 scopus 로고    scopus 로고
    • A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice
    • Shukla V, Zheng YL, Mishra SK, Amin ND, Steiner J, et al. (2013) A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J 27: 174-186.
    • (2013) FASEB J , vol.27 , pp. 174-186
    • Shukla, V.1    Zheng, Y.L.2    Mishra, S.K.3    Amin, N.D.4    Steiner, J.5
  • 23
    • 78650637437 scopus 로고    scopus 로고
    • Identification of low molecular weight pyroglutamate Aβ oligomers in Alzheimer's disease: A novel tool for therapy and diagnosis
    • Wirths O, Erck C, Martens H, Harmeier A, Geumann C, et al. (2010) Identification of low molecular weight pyroglutamate Aβ oligomers in Alzheimer's disease: a novel tool for therapy and diagnosis. J Biol Chem 285: 41517-41524.
    • (2010) J Biol Chem , vol.285 , pp. 41517-41524
    • Wirths, O.1    Erck, C.2    Martens, H.3    Harmeier, A.4    Geumann, C.5
  • 24
    • 81355124089 scopus 로고    scopus 로고
    • Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease
    • Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O (2012) Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging 33: 196. e29-40.
    • (2012) Neurobiol Aging , vol.33
    • Jawhar, S.1    Trawicka, A.2    Jenneckens, C.3    Bayer, T.A.4    Wirths, O.5
  • 25
    • 0036841466 scopus 로고    scopus 로고
    • Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1
    • DOI 10.1128/MCB.22.22.7967-7981.2002
    • Montag-Sallaz M, Schachner M, Montag D (2002) Misguided axonal projections, NCAM180 mRNA upregulation, and altered behavior in mice deficient for the Close Homolog of L1 (CHL1). Mol Cell Biol 22: 7967-7981. (Pubitemid 35217305)
    • (2002) Molecular and Cellular Biology , vol.22 , Issue.22 , pp. 7967-7981
    • Montag-Sallaz, M.1    Schachner, M.2    Montag, D.3
  • 26
    • 0037836943 scopus 로고    scopus 로고
    • Severe cognitive and motor coordination deficits in tenascin-R-deficient mice
    • DOI 10.1034/j.1601-183X.2003.00003.x
    • Montag-Sallaz M, Montag D (2003) Severe cognitive and motor coordination deficits in Tenascin-R-deficient mice. Genes Brain Behav 2: 20-31. (Pubitemid 36717660)
    • (2003) Genes, Brain and Behavior , vol.2 , Issue.1 , pp. 20-31
    • Montag-Sallaz, M.1    Montag, D.2
  • 27
    • 0002189671 scopus 로고    scopus 로고
    • Analysis of behavior in laboratory rodents
    • Windhorst, U. & Johansson, H., eds. Berlin Springer
    • Wishaw IQ, Haun F, Kolb B (1999) Analysis of behavior in laboratory rodents. In : Windhorst, U. & Johansson, H., eds. Modern Techniques in Neurosci Berlin Springer 1243-1275.
    • (1999) Modern Techniques in Neurosci , pp. 1243-1275
    • Wishaw, I.Q.1    Haun, F.2    Kolb, B.3
  • 28
    • 0031255352 scopus 로고    scopus 로고
    • Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment
    • Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8: 711-713. (Pubitemid 127739700)
    • (1997) Mammalian Genome , vol.8 , Issue.10 , pp. 711-713
    • Rogers, D.C.1    Fisher, E.M.C.2    Brown, S.D.M.3    Peters, J.4    Hunter, A.J.5    Martin, J.E.6
  • 29
    • 0037357946 scopus 로고    scopus 로고
    • Learning-induced arg 3.1/arc mRNA expression in the mouse brain
    • DOI 10.1101/lm.53403
    • Montag-Sallaz M, Montag D (2003) Learning-induced arg 3.1 expression in the mouse brain. Learn Mem 10: 99-107. (Pubitemid 36418720)
    • (2003) Learning and Memory , vol.10 , Issue.2 , pp. 99-107
    • Montag-Sallaz, M.1    Montag, D.2
  • 31
    • 33645520634 scopus 로고    scopus 로고
    • Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
    • Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, et al. (2006) Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 103: 5161-5166.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 5161-5166
    • Jacobsen, J.S.1    Wu, C.C.2    Redwine, J.M.3    Comery, T.A.4    Arias, R.5
  • 32
    • 0036193799 scopus 로고    scopus 로고
    • Comparative analysis of an improved thioflavin-S stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections
    • Sun A, Nguyen XV, Bing G (2002) Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J Histochem Cytochem 50: 463-472. (Pubitemid 34250585)
    • (2002) Journal of Histochemistry and Cytochemistry , vol.50 , Issue.4 , pp. 463-472
    • Sun, A.1    Nguyen, X.V.2    Bing, G.3
  • 33
    • 0034531476 scopus 로고    scopus 로고
    • Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model
    • Sturchler-Pierrat C, Staufenbiel M (2000) Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Ann N Y Acad Sci 920: 134-139. (Pubitemid 32056562)
    • (2000) Annals of the New York Academy of Sciences , vol.920 , pp. 134-139
    • Sturchler-Pierrat, C.1    Staufenbiel, M.2
  • 36
    • 0026569388 scopus 로고
    • An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease
    • Guntern R, Bouras C, Hof PR, Vallet PG (1992) An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48: 8-10.
    • (1992) Experientia , vol.48 , pp. 8-10
    • Guntern, R.1    Bouras, C.2    Hof, P.R.3    Vallet, P.G.4
  • 37
    • 84889260626 scopus 로고    scopus 로고
    • Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis
    • Annunziata I, Patterson A, Helton D, Hu H, Moshiach S, et al. (2013) Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis. Nat Commun 4: 2734.
    • (2013) Nat Commun , vol.4 , pp. 2734
    • Annunziata, I.1    Patterson, A.2    Helton, D.3    Hu, H.4    Moshiach, S.5
  • 38
    • 77957939522 scopus 로고    scopus 로고
    • Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain
    • Wengenack TM, Reyes DA, Curran GL, Borowski BJ, Lin J, et al. (2011) Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage 54: 113-122.
    • (2011) Neuroimage , vol.54 , pp. 113-122
    • Wengenack, T.M.1    Reyes, D.A.2    Curran, G.L.3    Borowski, B.J.4    Lin, J.5
  • 40
    • 84896765403 scopus 로고    scopus 로고
    • 5XFAD Tg mice that express five FAD mutations have high-cerebral aβ42 levels, rapid amyloid deposition, and intraneuronal aβ
    • Vassar RJ, Oakley H, Krishnamurthy S, Maus E, Shao P, et al. (2005) 5XFAD Tg mice that express five FAD mutations have high-cerebral aβ42 levels, rapid amyloid deposition, and intraneuronal aβ. Soc Neurosci Abstr 587: 2.
    • (2005) Soc Neurosci Abstr , vol.587 , pp. 2
    • Vassar, R.J.1    Oakley, H.2    Krishnamurthy, S.3    Maus, E.4    Shao, P.5
  • 41
    • 84868115047 scopus 로고    scopus 로고
    • Alzheimer's disease, Oestrogen and mitochondria: An ambiguous relationship
    • Grimm A, Lim YA, Mensah-Nyagan AG, Götz J, Eckert A (2012) Alzheimer's disease, Oestrogen and mitochondria: an ambiguous relationship. Mol Neurobiol 46: 151-160.
    • (2012) Mol Neurobiol , vol.46 , pp. 151-160
    • Grimm, A.1    Lim, Y.A.2    Mensah-Nyagan, A.G.3    Götz, J.4    Eckert, A.5
  • 42
    • 33847310829 scopus 로고    scopus 로고
    • Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease
    • DOI 10.1007/s00702-006-0580-9
    • Schaeffer S, Wirths O, Multhaup G, Bayer TA (2007) Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease. J Neural Transm 114: 387-394. (Pubitemid 46328658)
    • (2007) Journal of Neural Transmission , vol.114 , Issue.3 , pp. 387-394
    • Schafer, S.1    Wirths, O.2    Multhaup, G.3    Bayer, T.A.4
  • 43
    • 84872855216 scopus 로고    scopus 로고
    • Weight loss and Alzheimer's disease: Temporal and aetiologic connections
    • Sergi G, Rui MD, Coin A, Inelmen EM, Manzato E (2013) Weight loss and Alzheimer's disease: temporal and aetiologic connections. Proc Nutri Soc 72: 160-165.
    • (2013) Proc Nutri Soc , vol.72 , pp. 160-165
    • Sergi, G.1    Rui, M.D.2    Coin, A.3    Inelmen, E.M.4    Manzato, E.5
  • 44
    • 84879990946 scopus 로고    scopus 로고
    • Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
    • Webster SJ, Bachstetter AD, Van Eldik LJ (2013) Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease. Alzheimers Res Ther 5: 28.
    • (2013) Alzheimers Res Ther , vol.5 , pp. 28
    • Webster, S.J.1    Bachstetter, A.D.2    Van Eldik, L.J.3
  • 45
    • 76549087985 scopus 로고    scopus 로고
    • COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo
    • Tong Y, Xu Y, Scearce-Levie K, Ptácek LJ, Fu YH (2010) COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo. Neurogenet 11: 41-52.
    • (2010) Neurogenet , vol.11 , pp. 41-52
    • Tong, Y.1    Xu, Y.2    Scearce-Levie, K.3    Ptácek, L.J.4    Fu, Y.H.5
  • 46
    • 84858710947 scopus 로고    scopus 로고
    • APP transgenic mice for modelling behavioral and psychological symptoms of dementia (BPSD)
    • Lalonde R, Fukuchi K, Strazielle C (2012) APP transgenic mice for modelling behavioral and psychological symptoms of dementia (BPSD). Neurosci Biobehav Rev 36: 1357-1375.
    • (2012) Neurosci Biobehav Rev , vol.36 , pp. 1357-1375
    • Lalonde, R.1    Fukuchi, K.2    Strazielle, C.3
  • 47
    • 33644957833 scopus 로고    scopus 로고
    • Temporal memory deficits in Alzheimer's mouse models: Rescue by genetic deletion of BACE1
    • Ohno M, Chang L, Tseng W, Oakley H, Citron M, et al. (2006) Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur Jour Neurosci 23: 251-260.
    • (2006) Eur Jour Neurosci , vol.23 , pp. 251-260
    • Ohno, M.1    Chang, L.2    Tseng, W.3    Oakley, H.4    Citron, M.5
  • 48
    • 58149479368 scopus 로고    scopus 로고
    • Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model
    • Kimura R, Ohno M (2009) Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 33: 229-235.
    • (2009) Neurobiol Dis , vol.33 , pp. 229-235
    • Kimura, R.1    Ohno, M.2
  • 49
    • 0034893545 scopus 로고    scopus 로고
    • Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease
    • DOI 10.1176/appi.ajp.158.8.1319
    • Jessen F, Kucharsk C, Fries T, Papassotiropoulos A, Hoenig K, et al. (2001) Sensory Gating Deficit Expressed by a Disturbed Suppression of the P50 Event-Related Potential in Patients With Alzheimer's Disease. Am J Psychiatry 158: 1319-1321. (Pubitemid 32717710)
    • (2001) American Journal of Psychiatry , vol.158 , Issue.8 , pp. 1319-1321
    • Jessen, F.1    Kucharski, C.2    Fries, T.3    Papassotiropoulos, A.4    Hoenig, K.5    Maier, W.6    Heun, R.7
  • 51
    • 84861755926 scopus 로고    scopus 로고
    • Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease
    • Wang H, He J, Zhang R, Zhu S, Wang J, et al. (2012) Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease. Beh Brain Res 233: 237-243.
    • (2012) Beh Brain Res , vol.233 , pp. 237-243
    • Wang, H.1    He, J.2    Zhang, R.3    Zhu, S.4    Wang, J.5
  • 53
    • 77951158078 scopus 로고    scopus 로고
    • Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease
    • Seltzer B (2010) Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease. Clin Interv Aging 5: 1-6.
    • (2010) Clin Interv Aging , vol.5 , pp. 1-6
    • Seltzer, B.1
  • 54
    • 84885816253 scopus 로고    scopus 로고
    • Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection
    • Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, et al. (2013) Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection. Eur J Med Chem 70: 165-188.
    • (2013) Eur J Med Chem , vol.70 , pp. 165-188
    • Singh, M.1    Kaur, M.2    Kukreja, H.3    Chugh, R.4    Silakari, O.5
  • 55
    • 84871005647 scopus 로고    scopus 로고
    • Investigating the binding interactions of galantamine with b-amyloid peptide
    • Rao PPN, Mohamed T, Osman W (2013) Investigating the binding interactions of galantamine with b-amyloid peptide. Bioorg Med Chem Lett 23: 239-243.
    • (2013) Bioorg Med Chem Lett , vol.23 , pp. 239-243
    • Rao, P.P.N.1    Mohamed, T.2    Osman, W.3
  • 56
    • 33645114692 scopus 로고    scopus 로고
    • Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice
    • Unger C, Svedberg MM, Yu WF, Hedberg MM, Nordberg A (2006) Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. J Pharmacol Exp Ther 317: 30-36.
    • (2006) J Pharmacol Exp Ther , vol.317 , pp. 30-36
    • Unger, C.1    Svedberg, M.M.2    Yu, W.F.3    Hedberg, M.M.4    Nordberg, A.5
  • 57
    • 84872144291 scopus 로고    scopus 로고
    • A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice
    • Demattos RB, Lu J, Tang Y, Racke MM, Delong CA, et al. (2012) A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice. Neuron 76: 908-920.
    • (2012) Neuron , vol.76 , pp. 908-920
    • Demattos, R.B.1    Lu, J.2    Tang, Y.3    Racke, M.M.4    Delong, C.A.5
  • 58
    • 79959405630 scopus 로고    scopus 로고
    • Amyloid-β associated cortical thinning in clinically normal elderly
    • Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, et al. (2011) Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol 69: 1032-1042.
    • (2011) Ann Neurol , vol.69 , pp. 1032-1042
    • Becker, J.A.1    Hedden, T.2    Carmasin, J.3    Maye, J.4    Rentz, D.M.5
  • 59
    • 84858141828 scopus 로고    scopus 로고
    • Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
    • Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, et al. (2012) Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurol 78: 477-484.
    • (2012) Neurol , vol.78 , pp. 477-484
    • Chételat, G.1    Villemagne, V.L.2    Villain, N.3    Jones, G.4    Ellis, K.A.5
  • 60
    • 84861878510 scopus 로고    scopus 로고
    • The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease
    • Kalinin S, Polak PE, Lin SX, Sakharkar AJ, Pandey SC, et al. (2012) The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease. Neurobiol Aging 33: 1651-1663.
    • (2012) Neurobiol Aging , vol.33 , pp. 1651-1663
    • Kalinin, S.1    Polak, P.E.2    Lin, S.X.3    Sakharkar, A.J.4    Pandey, S.C.5
  • 61
    • 79951707099 scopus 로고    scopus 로고
    • Astrocytes: Implications for neuroinflammatory pathogenesis of Alzheimer's disease
    • Li C, Zhao R, Gao K, Wei Z, Yin MY, et al. (2011) Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res 8: 67-80.
    • (2011) Curr Alzheimer Res , vol.8 , pp. 67-80
    • Li, C.1    Zhao, R.2    Gao, K.3    Wei, Z.4    Yin, M.Y.5
  • 62
    • 75049085050 scopus 로고    scopus 로고
    • Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy
    • Maelicke A, Hoeffle-Maas A, Ludwig J, Maus A, Samochocki M, et al. (2010) Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy. J Mol Neurosci 40: 135-137.
    • (2010) J Mol Neurosci , vol.40 , pp. 135-137
    • Maelicke, A.1    Hoeffle-Maas, A.2    Ludwig, J.3    Maus, A.4    Samochocki, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.